The importance of analytical methodology in accurate diagnosis and monitoring of intrahepatic cholestasis of pregnancy

摘要

Intrahepatic cholestasis of pregnancy (ICP) is a liver disease with deleterious consequences for the fetus [1 ]. As soon as ICP is diagnosed, the mother should be considered a high-risk patient. Ursodeoxycholic acid (UDCA) treatment, coupled with close maternal-fetal monitoring, is indicated to optimize fetal outcome.